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1. Abstract
Composite magnetic nanoparticles provide the opportunity for direct umor targeting, thermal
therapy, and controlled rug release. However, the magnetic nanoparticles must be biocompatible in
order to be used in cancer therapy applications. Bycoating the magnetic nanoparticles with hydrogels,
we can decrease their toxicity while maintaining their property of heating in alternating magnetic f ields.
In this study, i t  was found that when the concentration f nanoparticles was increased, cel l  viabi l i ty
decreased. In the presented studies, the heat generated by these nanoparticle systems in an alternating
magnetic f ield was not enough to induce cell  death but i t  may be possible. For future studies, higher
concentrations of part icles and/or longer exposure t imes are recommended to induce cell  death.
2. Introduction
2.l Hyperthermia
Cancer is the second leading cause of death in the United States; therefore cancer therapy
research isgaining importance among today's researchers. Even though vast advancements in the
treatment of cancer have been made, there are still many types of cancer that have very low survival
rates and poor treatment success rates. Thus, novel therapies based on nanotechnologies are being
pursued ue their unique propert ies and potential to improve treatments. For example, composite
magnetic nanoparticles provide the opportunity for direct umor targeting, thermal therapy, and
control led rug release as shown in Figure 1.
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Figure 1. lron oxide coated in a hydrogel provides the opportunity for controlled drug release.
Hyperthermia, the heating of cancer tissue to between 41 and 45'C, has previously been proven
to induce cel l  death and when used in conjunct ion with other cancer treatments, such as chemotherapy
and radiation therapy, has shown improved efficacy [1]. However, there are many setbacks to using
hyperthermia s the main treatment of cancer.  The most common forms of hyperthermia today are
whole body hyperthermia nd regional hyperthermia. Whole body hyperthermia ut i l izes heat ing
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blankets or water baths in order to elevate the temperature of the body. Regional hyperthermia
removes blood surrounding the tumor si te,  heats the blood, and then pumps i t  back into the body and
through the tumor si te.  Many pat ients experience discomfort  as wel l  as burns near the tumor si te,  and
it  is di f f icul t  o have homogeneous distr ibut ion of heat across the tumor si te [2] .  Due to the lack of
abi l i ty to local ize hyperthermia to the cancer t issue, healthy t issue surrounding the cancer t issue is often
damaged. In the presence of an al ternat ing magnetic f ie ld,  composite magnetic nanopart ic les present
the opportunity for local ized hyperthermia within cancer t issue due to their  superparamagnetic
propert ies [3] .  As the magnetic f ie ld al ternates, heat can be generated through Neel and Brownian
relaxat ion. In high enough concentrat ions of nanopart ic les, the heat generated could induce cel l  death.
2.2 Tumor targeting magnetic nonoporticles
Composite magnetic nanopart ic les also provide the opportunity for direct tumor target ing.
These composite magnetic nanopart ic les, which consist  of  a magnetic ore and a polymer coat ing
loaded with ant i-cancer drug, can be injected into the tumor or directed to the tumor si te through the
use of an external magnet.  The vasculature of cancerous t issue is deformed and irregular which al lows
the nanopart ic les systems to permeate through the t issue and remain there due to the cancer t issue's
inabi l i ty to remove waste, otherwise known as the enhanced permeabi l i ty and retent ion effect (EPR) [4,
51. Uptake of the nanopart ic les into the cel ls has also been observed. Therefore, daughter cel ls of the
part ic le containing parent cel ls should contain up to 50% of the or iginal  part ic le amount [3] .  This
provides the opportunity for mult ip le heat ing sessions and an increased probabi l i ty of  inducing cel l
death on descendants of part ic le containing cel ls.  However,  EPR target ing methods do not require
part ic le uptake. Local ized heat ing of the tumor t issue is can be enough to induce cel l  death.
2.3 Stealth and temperature responsive polymers
One of the main di f f icul t ies of the composite magnetic nanopart ic les i their  biocompatibi l i ty,  The
healthy t issue surrounding the tumor wi l l  be exposed to the composite magnetic nanopart ic les so the
part ic les hould not induce cel l  death unless in the presence of an al ternat ing magnetic f ie ld.  By coat ing
the iron oxide nanoparticles with a biocompatible polymer, their cytotoxicity is decreased [6],
agglomerat ion of part ic les is prevented and circulat ion t ime increases [7].  PEG4OODMA is a stealth
polymer used to decrease the toxici ty of the i ron oxide nanopart ic le,  but i t  does not provide the
opportunity for drug loading and control led drug release.
OSWALD AWARDS 
FIRST PLACE - PHYSICAL AND ENGINEERING SCIENCES
Poly(N-isopropylacrylamide) (PNIPAAm) isa temperature responsive polymer with a lower cr i t ical
solut ion temperature (LCST) of about 32 "C in water.  Below this LCST, the polymer is hydrated and
hydrophi l ic.  Above the LCST, PNIPAAm is hydrophobic and col lapses on i tsel f .  By crossl inking
PNIPAAM with other polymers, the LCST can be increased to above body temperature. The behavior of
PNIPAAm and other temperature responsive polymers al lows for ant i -cancer drug to be loaded into the
polymer when i t  is below the LCST, and then released ur ing the sudden col lapse above the LCST [5].
Coat ing magnetic nanopart ic les with temperature responsive polymers would al low for ant i -cancer drug
to be del ivered irect ly to the tumor si te [8] .  Heat ing the i ron oxide core by an external al ternat ing
magnetic f ie ld would also heat the temperature responsive polymer coat ing. l f  the polymer coat ing was
heated to a temperature above i ts LCST, the polymer would col lapse and release the drug into the
cancerous t issue [9].  Therefore, coat ing the i ron oxide nanopart ic les with polymer does not only
decrease the toxici ty of the part ic les, but i t  a lso provides a method for direct drug del ivery. In this
study, the stealth polymer poly (ethylene glycol)400 dimethylacrylate (PEG40ODMA)was u ed to a
decrease in the toxici ty of the nanopart ic les, but plans for future experiments include test ing the toxici ty
of nanopart ic les coated with temperature responsive polymer systems.
The overall objective of this study was to synthesize and characterize composite magnetic
nanopart ic les for use as hyperthermia nd chemotherapeut ic-based treatments of cancer.  More
specif ical ly,  the goals were to prepare i ron oxide nanopart ic les coated with ci t r ic acid and PEG400DMA,
compare the viabi l i ty of  NIH 3T3 f ibroblasts and A549 lung cancer cel ls exposed to PEG4OODMA coated
iron oxide nanopart ic les, and to show increased nanopart ic le toxici ty in the presence of an al ternat ing
magnetic f ie ld.
3. Materials and Methods
3.L Moterials
The iron ( l l )  chlor ide tetrahydrate and iron ( l l l )chlor ide hexahydrate were purchased from
Sigma-Aldr ich (St.  Louis,  MO). Citr ic acid and ammonium hydride were obtained from Sigma-Aldr ich.
The 2,2-Dipyr idyl  (Bpy)and copper ( l )  bromide (CuBr)that were used in polymerizat ion were also
purchased from Sigma-Aldr ich. The ini t iator,  3-bromopropyltr imethoxysi lane (BPTS), was purchased
from Gelest (Morr isvi l le,  PA). Poly (el thylene glycol)400 dimethylacrylate (PEG400DMA) and poly(N-
isopropylacrylamide) (PNIPAAm), which were monomers used to coat the i ron oxide nanopart ic les,
were purchased from Polysciences, lnc. (Warr ington, PA).
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i.2 lron oxide nanoparticles preparation
Nanopart ic le systems were created using a one-pot co-precipi tat ion method. l ron ( l l l )  chlor ide
and iron ( l l )  chlor ide were combined in a 2:1 rat io respect ively with NH4OH in a three neck f lask and
vented with nitrogen gas. The temperature of the system was set to 85'C, and the speed of the impeller
was set to 300 rpm. After the system reached the specified temperature, L.68 grams of 2M citric acid
was added. The react ion was carr ied out for one hour,  and the nanopart ic les were separated by
magnetic decant ing, washed with ethanol,  and vacuum dried.
In order to coat the iron oxide nanoparticles with polymer, the nanoparticles were first coated
with an ini t iator,  3-bromopropyl t r imethoxysi lane (BPTS), v ia a l igand exchange with the ci t r ic acid.
BPTS puts bromine on the outside of the nanopart ic les which becomes a radical  in i t iator when heated.
This creates "seeds" for the polymer coating. BPTS and the iron oxide ratio are added to a three-neck
f lask in a2.5:t  rat io,  respect ively.  The system was purged with ni trogen gas and then sealed. The
react ion was run for 24 hours at room temperature with the impel ler rotat ing at 300 rpm.
3.3 Polymerization techniques
ln order to coat the nanoparticles in polymer, the steps to coat the nanoparticles with BPTS
ini t iator were f i rst  completed. The nanopart ic les were then added to a three neck f lask with Bpy and
CuBr, which were each diluted with ethanol. The system was set to run at 50'C, 300 rpm and for 6
hours. When the system reached 60"C, 5 grams of PEG4OODMA was added. After 6 hours, then
PEG400DMA coated nanopart ic les were washed in ethanol and vacuum dried. This same polymerizat ion
technique was used to synthesize the pNIPAAmPNIPAAm-PEG400DMA 15 weight% coated iron oxide
nanoparticles used in the NIH 3T3 cytotoxicity study as well. The structures of the polymers and initiator
are shown in Figure 2.
BPT$ initiator. 3-brornoprspyl
lrimethorc;silane
PEG{n}DhlA Poly {etthylene glycal} n
di rnethy-lacryl ate{n :400 }
PNIPAAm:poly{N-
isopropylacrylafiide)
Figure 2. Structures of BPTS initiator, PEG4OODMA and PNIPAAm.
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3.4 Characterization
FourierTransform lnfrored (FTIR)Spectro. Attenuated total reflectance FTIR (ATR-FTIR)was used
to conf irm the existence of specif ic funct ional groups on the surface of the i ron oxide nanopart ic les
using a Varian 7000e FTIR spectrophotometer. The spectrum was obtained from 800 to 4000cm-1 at a
resolut ion of 8 cm-1 for 32 scans. Dried composite magnetic nanopart ic les samples were placed on the
diamond ATR crystal  in order to col lect he spectrum.
Thermogravimetric Anolysis (TGA).Weight percent measurements were obtained from a Q500
TA instrument.  About 10mg of a sample was used at a heat ing rate of 20 'C/min. The sample was
heated to l -20"C and remained there for 10 minutes in order to evaporate any remaining water.  The
process was completed under nitrogen flow, and the TGA curves were normalized to I2O"C.
3.5 Controlled heoting
lron oxide nanopart ic les coated with PEG400DMA and NIAAm-PEG4OODMA L5wt% were
suspended in 4549 lung cancer media and exposed to an al ternat ing magnetic f ie ld.  Each of the
nanopart ic le systems was added to the media at concentrat ions of 100Ug/ml and 500;rg/ml,  which are
the same concentrat ions the 4549 lung cancer cel ls were exposed to in the cytotoxici ty study. A one
mil l i l i ter sample of the nanopart ic les solut ion was placed into a 2ml centr i fuge tube, which was then
placed inside Tef lon tube inside the coi l ,  and a f iber opt ic temperature probe (Luxtron FOT Lab Kit)  was
used to record the temperature of the nanopart ic le solut ions. The al ternat ing magnetic f ie ld was turned
on 30 seconds after the start  t ime, and lef t  on for 10 minutes. This procedure was completed three
t imes for each concentrat ion of the two nanopart ic les systems.
3.6 Cytotoxicity
NIH 3T3 murine f ibroblasts at passages 6-8 were cul tured in Dulbecco's Modif ied Eagle's
Medium supplemented with 70%v/v cal f  bovine serum, 10 prg/ml Fungizone ( lnvi trogen) ,  and2 Ve/ml
Penici l l in-Streptomycin-Glutamine (ATCC) in an incubator at 37"C and 5% COz. The f ibroblasts were then
seeded into 12-well plates at 5000cells/cm2 and incubated for 24 hours. Cytotoxicity studies of 4549
lung cancer cel ls were also completed. For these studies, 4549 lung cancer cel ls at passages 3 and 4
were cul tured in F-12K medium supplemented with 70%fetal  bovine serum, 10 pg/ml Fungizone, and 2
Ve/ml Penici l l in-Streptomycin-Glutamine and seeded into 12-wel l  plates at 6000cel ls f  cmz and incubated
for 24 hours. After 24 hours, the cells were exposed to the various concentrations of nanoparticles.
Nanopart ic les were added to cel l  media at concentrat ions of L00ir /ml and 500p/ml.  The nanopart ic le
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solut ions were vortexed and sonicated to dissolve the nanopart ic les into the media. After removal of  the
spent media, one mil l i l i ter of  the nanopart ic les solut ions was added to each wel l  containing the cel ls.
The control ,  which was exposed to no nanopart ic les, also had a change of media. The wel l  plates were
then put back in the incubator for 24 and 48 hours.
There were two methods of analyzing cytotoxicity. The first technique was completed using the
cellometer (Nexcelom Bioscience, Lawrence, MA). After 24 and 48 hours, the cells were removed from
the incubator, and the media was removed and placed into respective centrifuge tubes. The wells were
then washed with L25p1 of t rypsin, and then incubated with 250p1 of t rypsin to detach the cel ls from the
wel l  plate. After incubat ing for seven minutes, the cel ls and trypsin were removed from the wel l  plates
and placed into the centr i fuge tubes. A 2ml DPBS wash was then completed to insure al l  the cel ls were
being col lected. The cel l  solut ions were centr i fuged on a sett ing of three for three minutes. The
supernatant was then removed from the tubes, and the cel ls were re-suspended in 0.5 ml of l ive/dead
assay solut ion. The centr i fuge tubes were then placed back into the incubator for 20 minutes to al low
the cel ls to stain. After incubat ion, three 20pl samples were taken from each centr i fuge tube and
analyzed using the cel lometer.  The cel lometer provides the cel l  v iabi l i ty of  three 20gl samples, which are
then averaged to get the cel l  v iabi l i ty for that t r ia l .  In addit ion to cel l  v iabi l i ty,  the cel lometer also gives
the cel l  count,  cel l  concentrat ion, and mean size of the cel ls.
The second analyzing method used in the cytotoxicity studies involved a fluorescent microscope
(Nikon Ecl ipse LV 100, Melvi l le,  NY) and N|S-Elements BR 3.0 imaging software. After 24 and 48 hours,
the cel ls were removed from the incubator,  and the media was removed and discarded. The 2ml DPBS
wash was then completed to remove al l  remaining media. After discarding the DPBS wash, the l ive/dead
assay solut ion was added at 0.5m1 per wel l .  The cel ls were then returned to the incubator for 20
minutes before imaging. Five images ( l ive and dead) were taken of each wel l .  The number of l ive and
dead cel ls in each image were then counted using N|S-Elements BR 3.0 imaging software and averaged
to f ind the average cel l  v iabi l i ty of  each wel l .
3.7 Hyperthermia Demonstrotion
A hyperthermia demonstrat ion was completed on 4549 lung cancer cel ls.  The cel ls were cul tured in
F-12K media and seeded into 35mm dishes at 6000 cel ls/cm2. After seedin gfor 24 hours, the cel ls were
exposed to the nanopart ic les solut ions. For this study, cel ls were exposed to ci t r ic acid coated iron
oxide nanopart ic les, and PEG400DMA coated iron oxide nanopart ic les. Two concentrat ions (100pg/ml
and SOOprg/ml) of each system were studied. The first control was cells not exposed to particles, but
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exposed to the alternating magnetic field, and the second control was cells which were neither exposed
to nanoparticles or the alternating magnetic field. After exposure to the nanoparticles solutions, the
cells were placed in the incubator for three hours. The cells were then exposed to the alternating
magnetic f ield. The 35mm dishes were placed on the stage, centered on the coil ,  and exposed to the
alternating magnetic f ield for 10 minutes. After termination of the alternating magnetic f ield, the dish
was removed from the stage and placed back into the incubator for two hours. Cells were then stained
with Calcien AM and ethidium homodimer-l so the l ive cel ls are stained green and the dead cells are
stained red. Each dish was then imaged using the Nikon Eclipse 1V100 f luorescent microscope and NIS-
Elements BR 3.0 imaging software.
4. Results and Discussion
4.7 Choracterization
The FTIR results for iron oxide nanoparticles coated in PEG400DMA and NIPAAm-PEG400DMA
are shown in Figures 3 and 4 respectively. In Figure 3, the line drawn at 17L5 cm-1 indicates the presence
of a C=O and the line drawn at 1.105 cm-1 locates the valley corresponding to the C-O-C bonds. In Figure
4, the lines drawn at 1655 cm-1 and L620cm 1 correspond to the peaks which represent the C=O stretch
and 1540 cm-1 locates the valley which corresponds to N-H bending. Therefore, the presence of
PEG400DMA and NIPAAm-PEG400DMA 15wt% is confirmed ue to the presence of these peaks and
valleys.
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Figure 3. FTIR spectra of citric acid coated iron oxide, BPTS initiator, and functionalization with
PEG4OODMA.
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Figure 4. FTIR spectra of citric acid coated iron oxide, BPTS initiator, and functionalization with NIPAAm-
PEG4OODMA I5wt%
Thermogravimetric analysis can also be used to confirm the presence of a polymer coating on
the iron oxide nanoparticles and quantify the weight percent of polymer, but it also confirms the theory
that coating the iron oxide nanoparticles with polymer increases their stability. The citric acid coatinB
begins to degrade at a lower temperature than the PEG400DMA coating as displayed in Figure 5. The
rate of degradation isalso much higher for citric acid than PEG400DMA, which further confirms an
increase in stability by coating the nanoparticles with polymer. The final weight of the nanoparticles
coated with citric acid is also greater than the final weight of the iron oxide nanoparticles coated in
PEG400DMA, indicating agreater coating of polymer than citric acid. In the PEG400DMA coated iron
oxide nanoparticles, approximately L2% of the nanoparticle ispolymer, and the other 88% is the iron
oxide core.
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Figure 5. TGA of citric acid coated iron oxide nanoparticles and PEG400DMA, BPTS initiator, coated iron
oxide nanopart ic les.
The AMF heat ing capabi l i t ies of the composite magnetic nanopart ic les were determined using
alternat ing magnetic f ie ld heat ing. The part ic les were suspended in F-12K 4549 lung cancer cel l
medium, at var ious concentrat ions. As the concentrat ion of nanopart ic les in the cel l  medium increased,
the amount of heat generated ur ing exposure to an al ternat ing magnetic f ie ld also increased. l t  was
also observed that the nanoparticles coated in NIPAAm-PEG4OODMA Liwt% were heated to greater
temperatures than those coated in PEG400DMA at both concentrations. Since the nanoparticles do
generate heat in the presence of an al ternat ing magnetic f ie ld,  as shown in Figure 6, this presents the
question of whether the heat generated is enough to be used as hyperthermia to induce cell death.
l_1
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Figure 6. Heat ing prof i les of composite magnetic nanopart ic les in F-12K medium in an al ternat ing
magnetic field strength of 59.5kA/m.
4.2 Cytotoxicity of composite magnetic nanoparticles
NIH 3T3 f ibroblasts modela common cel l type found in the body. Cytotoxici ty studies were
completed on this cel l  l ine to model how composite magnetic nanopart ic les interact with and effect
non-cancerous cells. NIH 3T3 were exposed to four different nanoparticles ystems: Fe3Oa, Fe3Oa coated
with citric acid, PEG400DMA coated iron oxide, and NIPAAm-PEG400DMA 15wt% coated iron oxide.
Three concentrations (100Ug/ml, 500prg/ml and Lmg/ml) of each nanoparticles ystem were used. Cell
v iabi l i t ies were calculated using microscope imaging. Five images were taken per wel l .  The l ive and
dead cel ls in each image were counted and averaged with the other images of that wel l .  Then, the three
wells of the same nanoparticle system and concentration were averaged to get an overall cell viability.
Figure 7 shows that the cel l  v iabi l i t ies of the NIH 3T3 f ibroblasts exposed to the 100pg/ml
nanoparticles olutions were not significantly different from the control (not exposed to nanoparticles)
cel l  v iabi l i ty.  The 500pg/ml nanopart ic les solut ions proved to be more toxic to the cel ls than the
1-00pg/ml concentration. lron oxide without coating and PEG400DMA coated iron oxide were the only
two nanoparticles ystems with not significantly different cell viabilities from the control for either 48 or
24 hours. The Lmg/ml concentration appears to be very toxic due to all nanoparticle systems, except for
L2
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PEG4OODMA coated, to have a significant difference in cell viability from the control. This trend of
increasing nanopart ic les concentrat ion, decreasing cel l  v iabi l i ty is to be expected.
Within each concentration of nanoparticles, it was expected that the polymer coated
nanopart ic les would increase cel l  v iabi l i ty when compared to the non-coated iron oxide and ci tr ic acid
coated iron oxide. Al though in many cases the viabi l i ty of  the cel ls exposed to polymer coated
nanoparticles was greater than the others, it was not significant, as shown in Table 1. The p-values
comparing the non-coated and ci tr ic acid coated iron oxide core nanopart ic les to the polymer coated
nanoparticles were greater than 0.05, not indicating a significant difference. However, there was a
significant difference between increasing concentrations of the same nanoparticles ystems. Therefore,
we can say with conf idence that increasing the nanopart ic les concentrat ion does decrease cel l  v iabi l i ty.
Figure 7. NIH 3T3 fibroblast cell viability after exposure to Fe3O4, Fe3O4+CA and PEG400DMA
nanopart ic les. Dark bars represent 24 hours and l ight bars represent 48 hours. The error is reported as
standard error.
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i tat ist icalAnalysis of NIH 3T3 Viabi l i t ies
100 uglml i00 uglml I mg/ml
:e3O4 (24 hours) 3>0.05 0>0.o5
:e3O4 (48 hours) r>0.05
:e3O4 + Citric Acid (24 hours) r>0.05
:e3O4 + Citric Acid (48 hours) '>0.05
)EG400DMA (24 hours) r>0.05
,EG400DMA (48 hours) l>o.05 c>0.05 )>0.05
Table 1. Stat ist ical  analysis of NIH 3T3 f ibroblast v iabi l i t ies. This table compares the viabi l i t ies of the
control  cel ls to the cel ls which have been exposed to nanopart ic le systems. A p-value greater than 0.5
(shaded in green) indicates no signi f icant di f ference between the control  v iabi l i ty and the nanopart ic le
system viabi l i ty.  A p-value less than 0.5 (shaded in red) indicates a signif icant di f ference in cel l  v iabi l i ty
between the control and the nanoparticle system, therefore, they could be considered toxic.
Cytotoxici ty studies with 4549 lung cancer cel ls were also completed to determine how the
composite magnetic nanopart ic les interact with cancer cel ls.  The cel ls were cul tured as stated above,
and exposed to two nanopart ic le systems and two concentrat ions of each system. Cel l  v iabi l i t ies were
calculated using the cel lometer method out l ined in the mater ials and methods sect ion.
As with the NIH 3T3 f ibroblasts,  the 100pg/ml nanopart ic le solut ions do not signi f icant ly decrease
cel l  v iabi l i ty as shown in Figure 8. Only the 100p/ml PEG4OODMA became toxic after 48 hours. Not
experiencing a signi f icant decrease in the viabi l i ty of  cel ls exposed to the 100pg/ml concentrat ions of
the nanopart ic le systems, could indicate biocompatibi l i ty at  this concentrat ion. However,  when the
concentrat ion is increased to 500pg/ml al l  the nanopart ic le systems caused a decrease in cel l  v iabi l i ty,
except when exposed to PEG400DMA for only 24 hours.
A549 lung cancer cel ls did not experience a signif icant drop in viabi l i ty when the concentrat ion of
the same nanopart ic le system was increased. For example, Table 2 does not show a stat ist ical
difference between the viabilities of cells exposed to 100pg/ml Fe3Oo+CA and does show a statistical
significance to those exposed to 500pg/ml Fe3Oo+CA after 24 hours when compared to the control.
1.4
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Figure 8. A549 lung cancer cell viabilities 24 and 48 hours after exposure to iron oxide coated in citric
acid and PEG400DMA coated irofr oxide nanoparticles. Error is reported as standard error.
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tat ist ical  Analysis of A549 lung cancer viabi l i t ies
100 uglml
3O4 + Citr ic Acid (24 hours)
3O4 + Citr ic Acid (48 hours)
G400DMA (24 hours)
A (48 hours)
Table 2. Statst ical  analysis of A549 lung cancer cel ls.  A p-value greater than 0.5 (shaded in green)
indicates no stat ist ical  di f ference between the control  v iabi l i ty and the nanopart ic le system. A p-value
T6
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less than 0.5 (shaded in red) indicates a signif icant di f ference between the control  v iabi l i ty and the
nanoparticle system, therefore, they could be considered toxic.
4. 3 Hy pe rthe rm i a De m o n strati on
4549 lung cancer cel ls which had been exposed to composite magnetic nanopart ic les were also
exposed to an al ternat ing magnetic f ie ld,  in hopes of proving that the heat generated by the
nanopart ic les i enough to induce cel l  death. Figure 5 showed that in the presence of an al ternat ing
magnetic f ie ld,  the magnetic nanopart ic les do generate heat.  However,  when the cel ls and
nanopart ic les were exposed to the same al ternat ing magnetic f ie ld,  the heat generated was not enough
t o i n d u c e c e l l d e a t h .  T h e i m a g e s i n F i g u r e l 0 w e r e t a k e n a t t h e c e n t e r o f t h e 3 5 m m d i s h .  T h e c e l l s i n
these images are al ive with minimal dead cel ls.  Had the heat generated by the part ic les been enough to
induce cel l  death, i t  would have been expected to see a major i ty of dead cel l  at  the center of the dish. l t
is possible to increase the heat generated by increasing the nanopart ic le concentrat ions, however,  this
could also decrease cel l  v iabi l i ty in cel ls not exposed to an al ternat ing magnetic f ie ld.  Future
experiments wi l l  be completed to determine the opt imum concentrat ion of nanopart ic les that wi l l  both
generate enough heat to induce cel l  death and al low for high cel l  v iabi l i ty when not exposed to an
alternat ing magnetic f ie ld.
Control-No AM F/No particles Control-AM F/No particles
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100ug/ml Fe3O4+CA 100ug/ml PEG400DMA
500ug/ml Fe3O4+CA 500ug/ml PEG400DMA
Figure 10. Live/dead images of A549 cells exposed to nanoparticle systems and then exposed to an
alternat ing magnetic f ie ld for l -0 minutes.
5. Conclusions
It  was found that increasing the nanopart ic le concentrat ion to which cel ls are exposed,
decreases cel l  v iabi l i ty.  This trend was observed when using both NIH 3T3 f ibroblasts and 4549 lung
cancer cel ls.  The 100pg/ml concentrat ion of the nanopart ic le solut ions did not produce signi f icant ly
different cell viabilities from the control, and therefore could be considered biocompatible. However, as
the concentrat ion was increased, the nanopart ic les became toxic to the cel ls,  as the cel l  v iabi l i t ies
became significantly less than the control. In the future, we hope to prove that by coating iron oxide
nanopart ic les with polymer i t  is possible to make them more biocompatible.  Whi le some of the results
support  his trend, the results are not signi f icant.
When magnetic nanopart ic le suspended in 4549 cel l  media were exposed to an al ternat ing
magnetic f ie ld,  the nanopart ic les generated heat.  However,  this heat was not enough to induce cel l
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death when both A549 lung cancer cel ls and magnetic nanopart ic les were exposed to an al ternat ing
magnetic f ie ld.  This could be due to the concentrat ion of nanopart ic les not being high enough, but the
concentrat ions must remain low enough so that cel l  v iabi l i ty when not exposed to the al ternat ing
magnetic f ie ld remains high. Therefore, the next step of this research wi l l  be to develop nanopart ic les
that generate enough heat in an al ternat ing magnetic f ie ld to induce cel l  death, but do not induce cel l
death otherwise.
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